Novozymes A/S
NSIS-B
Rang in aandelen
#821
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global... Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
Aandeelprijs
$71.08
Marktkapitalisatie
$29.32B
Verandering (1 dag)
1.13%
Verandering (1 jaar)
11.94%
Land
DK
Handel Novozymes A/S (NSIS-B)
Categorie
Basic Materials
Operationele marge voor Novozymes A/S (NSIS-B)
Operationele marge op 2026 TTM: 0.00%
Volgens de meest recente financiële rapporten en aandelenkoers van Novozymes A/S is de huidige operationele marge (TTM) 0.00%. Eind 2026 had het bedrijf een operationele marge van 0.00%.
Geschiedenis van de operationele marge van Novozymes A/S van 2013 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2025 | 21.23% | 23.50% |
| 2024 | 17.19% | -22.60% |
| 2023 | 22.21% | -15.78% |
| 2022 | 26.37% | -1.60% |
| 2021 | 26.80% | 2.84% |
| 2020 | 26.06% | 4.41% |
| 2019 | 24.96% | -13.63% |
| 2018 | 28.90% | 1.94% |
| 2017 | 28.35% | 0.14% |
| 2016 | 28.31% | -1.94% |
| 2015 | 28.87% | 9.52% |
| 2014 | 26.36% | 7.50% |
| 2013 | 24.52% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 27.10% | - |
GB
|
|
| 21.22% | - |
FR
|
|
| 16.36% | - |
US
|
|
| 17.37% | - |
US
|
|
| -4.71% | - |
US
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.